PTX3 and Stroke: Collectively, our findings are clinically important as they strongly suggest that PTX3 aids long-term recovery of CBF after cerebral ischaemia, possibly mediated by mechanisms of ECM remodelling and angiogenesis, and therefore that upregulating PTX3 is a promising therapeutic strategy to improve outcome in stroke patients.